The prevalence and genotypic distribution of group A rotavirus detected from patients with acute gastroenteritis patients in Incheon

Journal of Bacteriology and Virology

Volumn 37, Issue 1, 2007, Pages 39-45

  Lee, Jea Mann ^a   Kim, Hye Young ^a   Lee, Mi Yeon ^a   Lee, Kang Bum ^b   Cheon, Doo Sung ^b   Jee, Young Mee ^b  

^a Incheon Institute of Health and Environment ^*  (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

ELISA; Genotypes; Rotavirus; RT PCR

Indexed keywords

ACUTE GASTROENTERITIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; GENETIC ANALYSIS; GENOTYPE; GROUP A ROTAVIRUS; HUMAN; NONHUMAN; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; SCREENING; SEQUENCE ANALYSIS; SOUTH KOREA; VIRUS DETECTION; VIRUS INFECTION;

ROTAVIRUS; ROTAVIRUS A;

EID: 44849114300     PISSN: 15982467     EISSN: None     Source Type: Journal    
DOI: 10.4167/jbv.2007.37.1.39     Document Type: Article

References (28)

1. Glass RI: Importance of rotavirus and adenovirus types 40 and 41 in acute gastroenteritis in Korean children. J Clin Microbiol 28: 2279-2284, 1990.
2. Korean source
3. Korean source
4. J Bacteriol Virol 35: 67-74, 2005.
5. Korean source
6. Korean source
7. Korean source
8. Beards G, Desselberger U, Flewett TH: Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988. J Clin Microbial 27: 2827-2833, 1989.
9. Bern C, Martines J, Zoysa I, Glass RI: The magnitude of the global problem of diarrheal disease: a ten-year up-date. Bull WHO 70: 705-714, 1992.
10. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK: Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30: 1365-1373, 1992.
11. Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, Fang YZ: Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 28: 276-282, 1990.
12. Guilermo M, Ruiz P: Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritidis. the New England Journal of Medicine 354: 11-22, 2006.
13. Hwa-Gan HC, Perry FS, Joel A, MPH, Dale LM, RPGER I: Intussusception, Rotavirus Diarrhea, and Rotavirus vaccine Use Among Children in New York State. PEDIATRICS 108: 54-60, 2001.
14. Hoshino Y, Sereno MM, Midthum K: Independent segregation of two antigenic specificities (VP4 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci USA 82: 8701-8704, 1985.
15. Irene PS, María JG, Mireya P, Vito P, Ana MR, Rosabel G, Walter C, Yasutaka H, Albert Z: Efficacy of the Rhesus: Efficacy of the Rhesus Rotavirus-based Quadrivalent Vaccine in Infants and Young children in Venezuela. N Engl J Med 337: 1181-1187, 1997.
16. Kang G: Rotavirus vaccines. Indian J Med Microbiol 24(4): 252-257, 2006.
17. Kang JO, Kim CR, Kilgore PE, Choi TY: G and p genotyping of human rotavirus isolated in a University hospital in Korea: implications for nosocomial infections. Korean Med Sci 21(6): 983-988, 2006.
18. Kapikian AZ, Flores J, Hoshino Y: Rotavirus: The Major etiologic agent of severe infantile diarrhea may be controllable by a " Jennerian" approach to vaccination. J Infect Dis 153: 815-822, 1986.
19. Kapikian AZ, Wyatt RG, Dolin R: Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 10: 1075-1081, 1972.
20. Martella V, Ciarlet M, Camarda A, Pratelli A, Tempesta M, Greco G, Cavalli A, Elia G, Decaro N, Terio V, Bozzo G, Camero M, Buonavoglia C: Molecular characterization of the VP4, VP6, VP7, and NSP4 genes of lapine rotaviruses identified in Italy emergence of a novel VP4 genotype. Virology 314: 358-370, 2003.
21. Matty AS, Marion PG, Koopmans M, Laetitia M, Kortbeek, Leeuwen NJ, Bartelds AIM, Yvonne THP, van Duynhoven: Gastroenteritis in sentinel general practices, the Netherland. Emerg Infect Dis 1: 82-91, 2001.
22. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI: Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9: 565-572, 2003.
23. Parashar U. Session 1: Epidemiology and disease burden. In: Proceedings of the Sixth International Rotavirus Symposium, Mexico City, 6: 7-9, 2004.
24. Penina Haber, Robert T. Chen, MA, Lynn R. Zanardi, Gina T. Mootrey, DO, Roseanne English, M. Miles Braun: An Analysis of Rotavirus Vaccine Reports to the Vaccine Adverse Event Reporting System. PEDIATRICS 113: 353-359, 2004.
25. Prasad BV, Wang GJ, Clerx JP, Chiu W: Three-dimensional structure of rotavirus. J Mol Biol 199: 269-275, 1988.
26. Rahman M, Matthijnssens J, Nahar S, Podder G, Sack DA, Azim T, Van Ranst M: Characterization of a novel P[25],G11 human group A rotavirus. J Clin Microbiol 43: 3208-3212, 2005.
27. Seo JK, Sim JK: Overview of rotavirus infections in Korea. Pediatr Int 42: 406-410, 2000.
28. Timo V, David O: Safety and Efficacy of a pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine. the New England Journal of Medicine 354: 23-33, 2006.